a public good project by the
Synthesis
Company
of California

© 2026

Eric Kuhn | doi.page

0 works0 citations0 h-index

Eric Kuhn

Woomera Therapeutics(US)C4 Therapeutics (United States)(US)

Publications by Year

Research Areas

Advanced Proteomics Techniques and Applications, Mass Spectrometry Techniques and Applications, Cancer-related Molecular Pathways, Monoclonal and Polyclonal Antibodies Research, Prion Diseases and Protein Misfolding

Most-Cited Works

→ Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer(2016)1,090 cited
→ Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities(2019)819 cited
→ Quantitative, Multiplexed Assays for Low Abundance Proteins in Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution(2007)679 cited
→ Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach(2014)553 cited
→ Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy(2020)532 cited
→ Quantification of C‐reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C‐labeled peptide standards(2004)398 cited

→ Refined Preparation and Use of Anti-diglycine Remnant (K-ε-GG) Antibody Enables Routine Quantification of 10,000s of Ubiquitination Sites in Single Proteomics Experiments(2012)347 cited

→ Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution(2009)284 cited

→ Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis(2004)282 cited

→ Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry(2009)247 cited